An observational study in Obesity, Type 2 Diabetes Mellitus and Bariatric Surgery, sponsored by China-Japan Friendship Hospital. Recruiting at 1 site in China. Open to participants aged 16 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-08-03.
Sponsored by China-Japan Friendship Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Obesity by China-Japan Friendship Hospital — 8 open to participants now, 8 under way, none of them phase 3. Obesity · China-Japan Friendship Hospital.
Among the 10 studies in Obesity by China-Japan Friendship Hospital, this one is one of 3 that started in 2024, is one of 5 observational ones, and was the 1st registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →8 of the 10 studies in Obesity by China-Japan Friendship Hospital are open now, in 1 country. Recruiting first, the newest first:
China-Japan Friendship Hospital · Sites in China
Ages 18–60
China-Japan Friendship Hospital · Sites in China
Ages 18–65
China-Japan Friendship Hospital · Sites in China
Ages 18–65
China-Japan Friendship Hospital · Sites in China
Ages 16–70
China-Japan Friendship Hospital · Sites in China
Ages 18–60
By country, each count listing its studies:
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 16 Years to 70 Years · all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 3 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 800 is above the median of 115 across 2,159 observational studies indexed under Obesity.
Median enrollment 200 across the 5 interventional studies, 800 across the 5 observational. Of the 2 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
China-Japan Friendship Hospital is the lead sponsor of 179 studies on the registry; 112 are open to participants now.
3 of the studies in Obesity by China-Japan Friendship Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07236788China-Japan Friendship HospitalStudy on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency. | 2026-12-30 |
| NCT06169033China-Japan Friendship HospitalRadiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS) | 2026-12-31 |
| NCT07335731China-Japan Friendship HospitalStudy on the Safety and Efficacy of Domestic Single-Port Robot-Assisted Metabolic Bariatric Surgery. | 2027-04-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 10 studies in Obesity by China-Japan Friendship Hospital, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Using radiomics of intra-abdominal and subcutaneous adipose tissue and clinical features to predict the weight loss efficacy and remission of type 2 diabetes mellitus after bariatric surgery.
In this study, the investigator intend to collect abdominal CT from patients who are proposed to undergo bariatric surgery, to extract the radiomics of intra-abdominal fat and subcutaneous fat, and to establish a prediction model for predicting the efficacy of weight loss and remission of type 2 diabetes mellitus at 1 year, 3 years, and 5 years postoperatively, in conjunction with the clinical data.
Obese patients with type 2 diabetes who will undergo bariatric surgery (sleeve gastrectomy or Roux-en-Y gastric bypass) and receive abdominal CT scan will be included in the study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Area under curve (AUC) of the weight loss prediction model after 1 year
This metric shows the discriminatory ability of the radiomic model to predict the probability of inadequate weight loss after 1 year.
Time frame: 1 year
Area under curve (AUC) of the T2DM remission prediction model after 1 year
This metric shows the discriminatory ability of the radiomic model to predict the probability of remission of T2DM after 1 year.
Time frame: 1 year
Area under curve (AUC) of the weight loss prediction model after 3 years
This metric shows the discriminatory ability of the radiomic model to predict the probability of inadequate weight loss after 3 years.
Time frame: 3 years
Area under curve (AUC) of the T2DM remission prediction model after 3 years
This metric shows the discriminatory ability of the radiomic model to predict the probability of remission of T2DM after 3 years.
Time frame: 3 years
Area under curve (AUC) of the weight loss prediction model after 5 years
This metric shows the discriminatory ability of the radiomic model to predict the probability of inadequate weight loss after 5 years.
Time frame: 5 years
Area under curve (AUC) of the T2DM remission prediction model after 5 years
This metric shows the discriminatory ability of the radiomic model to predict the probability of remission of T2DM after 5 years.
Time frame: 5 years
Area under curve (AUC) of the weight regain model
This metric shows the discriminatory ability of the radiomic model to predict the probability of weight regain.
Time frame: 5 years
Area under curve (AUC) of the T2DM relapse model
This metric shows the discriminatory ability of the radiomic model to predict the probability of T2DM relapse.
Time frame: 5 years
Plan to share: Undecided — Subject information involves medical and personal privacy and access is subject to the consent of the principal investigator.
No publications or documents are linked to this record.
Started Jan 2024 (actual). Primary completion is estimated for Dec 2026, 35 months after the start.
Of 796 non-industry observational studies under Obesity, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 106. This study's planned 35 months is below that.
Counting every sponsor, half of 842 studies reached it within 39 months; a quarter within 17 and three quarters within 96.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
China-Japan Friendship Hospital →